News Uric Acid-Lowering Therapy May Increase Risk for CKD By Natasha Persaud Publish Date June 22, 2022
Drugs in the Pipeline Beti-Cel, a Gene Therapy for Beta-Thalassemia, Gets FDA Panel Support By Brian Park, PharmD Publish Date June 13, 2022
News Bristol Myers Squibb Withdraws Luspatercept sBLA for NTD Beta Thalassemia By Brian Park, PharmD Publish Date June 6, 2022
News Methylprednisolone Slows Progression in IgA Nephropathy By Natasha Persaud Publish Date June 2, 2022
News Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population By Jody A. Charnow Publish Date May 27, 2022
News Optimal Difelikefalin Dose Reported for Pruritus in Hemodialysis By Natasha Persaud Publish Date May 23, 2022
Drugs in the Pipeline Sparsentan Gets Priority Review for IgA Nephropathy By Brian Park, PharmD Publish Date May 17, 2022
Safety Alerts and Recalls FDA Warns of Potential Chemical Exposure With Certain Hemodialysis Machines By Brian Park, PharmD Publish Date May 9, 2022
News Combining Dapagliflozin and Eplerenone Further Reduces Albuminuria in CKD By Natasha Persaud Publish Date April 29, 2022
News Underuse of Diabetic Kidney Disease Therapies Reported By Natasha Persaud Publish Date April 29, 2022
Drugs in the Pipeline FDA to Review Daprodustat for Anemia of Chronic Kidney Disease By Brian Park, PharmD Publish Date April 19, 2022
Drugs in the Pipeline Trials Investigating Bempegaldesleukin in Combination With Nivolumab Discontinued By Brian Park, PharmD Publish Date April 18, 2022
News Bevacizumab Biosimilar Alymsys Gets FDA Approval By Brian Park, PharmD Publish Date April 14, 2022
News RAASi Dose Reduction, Discontinuation in CKD Common After Hyperkalemia By Jody A. Charnow Publish Date April 13, 2022
Drugs in the Pipeline Enrollment Paused in Trials Evaluating BCX9930 for Complement-Mediated Diseases By Brian Park, PharmD Publish Date April 8, 2022
News Daprodustat Possibly an Oral Alternative to ESAs in Incident Dialysis By Jody A. Charnow Publish Date April 8, 2022
News Anaphylaxis Rare With IV Iron Use, But Risk Varies By Formulation By Natasha Persaud Publish Date April 5, 2022
Drugs in the Pipeline March 2022: Drug Pipeline Updates By Brian Park, PharmD Publish Date April 4, 2022
Drugs in the Pipeline FDA Says No to Vadadustat Approval Due to Safety Concerns By Brian Park, PharmD Publish Date April 1, 2022